Flatiron Health, Purchased By Roche, Signs Three-Year Deal With Bristol-Myers

Retrieved on: 2018-05-01 19:26:15

Tags for this article:

Health

Clinical trial

Food and Drug Administration

Click the tags to see associated articles and topics

Flatiron Health, Purchased By Roche, Signs Three-Year Deal With Bristol-Myers. View article details on hiswai:

Excerpt

<div><b>Flatiron Health</b> was purchased by Roche, the Swiss drug giant, for $1.9 billion in February. At the time, the New York startup said that it would still be open for business with other drug companies. It wasn't kidding. This morning, Flatiron and Bristol-Myers Squibb are announcing a new three-year ...</div>

Article found on:

View Original Article